| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 81.074.081 $ | +17.446.283 $ | +120,3 % | 10 | 107.942.080 $ | +78.335.656 $ | +243,5 % | 10 | 30.442.455 $ | +18.840.315 $ | +79,6 % | 5 | ||||
| Cidara Therapeutics, Inc. | → 0 | 18.797.297 $ | +12.241.280 $ | +186,7 % | 1 | 6.556.017 $ | +6.556.017 $ | 1 | |||||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 17.928.591 $ | +11.998.350 $ | +202,3 % | 1 | 5.930.241 $ | +1.130.921 $ | +23,6 % | 1 | |||||
| Summit Therapeutics Inc. | SMMT | → 0 | Neutral | 16.928.872 $ | +12.853.625 $ | +315,4 % | 1 | ||||||||
| UroGen Pharma Ltd. | URGN | → 0 | Neutral | 6.964.931 $ | -9.858.920 $ | -58,6 % | 1 | 16.823.851 $ | +15.070.007 $ | +859,3 % | 1 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 8.666.331 $ | -4.342.443 $ | -33,4 % | 1 | 13.008.774 $ | +7.818.955 $ | +150,7 % | 1 | ||||
| Immunovant, Inc. | IMVT | → 0 | Neutral | 8.882.933 $ | +1.544.764 $ | +21,1 % | 1 | 7.338.169 $ | +1.835.639 $ | +33,4 % | 1 | 5.502.530 $ | +5.502.530 $ | 1 | |
| Savara Inc | SVRA | → 0 | Stark | 8.659.434 $ | +2.657.455 $ | +44,3 % | 1 | 6.001.979 $ | +1.328.006 $ | +28,4 % | 1 | ||||
| DYNAVAX TECHNOLOGIES CORP | DVAX | → 0 | 8.083.605 $ | +8.083.605 $ | 1 | ||||||||||
| Sionna Therapeutics, Inc. | SION | → 0 | Neutral | 5.653.652 $ | -1.775.944 $ | -23,9 % | 1 | 7.429.596 $ | +7.429.596 $ | 1 | |||||
| Axsome Therapeutics, Inc. | AXSM | → 0 | Schwach | 6.836.763 $ | +6.836.763 $ | 1 | |||||||||
| Zai Lab Ltd | ZLAB | → 0 | Neutral | 6.799.283 $ | +2.082.005 $ | +44,1 % | 1 | ||||||||
| Definium Therapeutics, Inc. | DFTX | → 0 | Neutral | 6.642.613 $ | +949.158 $ | +16,7 % | 1 | 5.693.455 $ | +5.693.455 $ | 1 | |||||
| Vir Biotechnology, Inc. | VIR | → 0 | Neutral | 6.545.710 $ | +5.687.428 $ | +662,7 % | 1 | ||||||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 6.418.482 $ | +6.418.482 $ | 1 | |||||||||
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 5.711.123 $ | +3.312.678 $ | +138,1 % | 1 | ||||||||
| 89bio, Inc. | → 0 | 5.654.384 $ | +3.568.842 $ | +171,1 % | 1 | ||||||||||
| 81.074.081 $ | +17.446.283 $ | +120,3 % | 10 | 107.942.080 $ | +78.335.656 $ | +243,5 % | 10 | 30.442.455 $ | +18.840.315 $ | +79,6 % | 5 | ||||